Endogenous opioids: Overview and current issues

Drug and Alcohol Dependence

Volumn 51, Issue 1-2, 1998, Pages 127-140

  Akil, Huda ^a   Owens, Constance ^a   Gutstein, Howard ^a   Taylor, Larry ^a   Curran, Eileen ^a   Watson, Stanley ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR; DYNORPHIN A; ENDORPHIN; MORPHINE; OPIATE; OPIATE RECEPTOR; PROOPIOMELANOCORTIN;

AMINO ACID SEQUENCE; BINDING SITE; HUMAN; INTERNALIZATION; LIGAND BINDING; MOLECULAR BIOLOGY; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR AFFINITY; REVIEW; REWARD; SECOND MESSENGER; SEQUENCE HOMOLOGY;

EID: 0032104656     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(98)00071-4     Document Type: Article

References (146)

1. Akil, H., Watson, S.J., 1994. Cloning of kappa opioid receptors: functional significance and future directions. In: Bloom, F.E. (Ed.), Neuroscience: From the Molecular to the Cognitive. Elsevier Publishers, Amsterdam.
2. Akil, H., Mayer, D.J., Liebeskind, J.C., 1976. Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science 191, 961-962.
3. Akil, H., Mayer, D.J., Liebeskind, J.C., Fessard, M.A., 1972. Comparison chez le rat entre l'analgesie induite par stimulation de la substance grise peri-aqueducale et l'analgesie morphinique. C.R. Acad. Sci. Paris Ser. D 274, 3603-3605.
4. Akil, H., Watson, S.J., Young, E., Lewis, M.E., Khachaturian, H., Walker, J.M., 1984. Endogenous opioids: biology and function. In: Cowan, W.M. (Ed.), Annual Review of Neuroscience, vol. 7. Annual Reviews, Palo Alto, pp. 223-255.
5. Akil, H., Young, E., Watson, S.J., Coy, D., 1981. Opiate binding properties of naturally occurring N-and C-terminus modified beta-endorphin. Peptides 2, 289-292.
6. Avidor-Reiss, T., Nevo, I., Levy, R., Pfeuffer, T., Vogel, Z., 1996. Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of G beta-gamma. J. Biol. Chem. 271, 21309-21315.
7. Bals-Kubik, R., Herz, A., Shippenberg, T.S., 1988. β-Endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids. Naunyn-Schmied. Arch. Pharmacol. 338, 392-396.
8. Beckett, A.H., Casy, A.F., 1954. Synthetic analgesics: stereochemical considerations. J. Pharm. Pharmacol. 6, 986-1001.
9. Befort, K., Mattei, M.-G., Roeckel, N., Kieffer, B., 1994. Chromosomal localization of the δ opioid receptor gene to human 1p34.3-p36.1 and mouse 4D bands by in situ hybridization. Genomics 20, 143-145.
10. Berhow, M.T., Hiroi, N., Nestler, E.J., 1996. Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16, 4707-4715.
11. Berhow, M.T., Russell, D.S., Terwilliger, R.Z., et al., 1995. Influence of neurotrophic factors on morphine and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience 68, 969-979.
12. Bloom, F.E., Rossier, J., Battenberg, E., et al., 1978. Beta-endorphin: cellular localization, electrophysiological and behavioral effects. Adv. Biochem. Psychopharmacol.: The Endorphins. 18, 89-109.
13. Blumer, K.J., Johnson, G.L., 1994. Diversity in function and regulation of MAP kinase pathways. Trends Biochem. Sci. 19, 236-240.
14. Boulton, T.G., Nye, S.H., Robbins, D.J., et al., 1991. ERKs: a family of protein-serine/threoninie kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65, 663-675.
15. Boulton, T.G., Yancopoulos, G.D., Gregory, J.S., et al., 1990. An insulin-stimulated protein kinase homologous to yeast kinases involved in cell cycle control. Science 249, 64-67.
16. Bunzow, J.R., Saez, C., Mortrud, M., et al., 1994. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or κ opioid receptor type. FEBS Lett. 347, 279-283.
17. Burt, A.R., Carr, I.C., Mullaney, I., Anderson, N.G., Milligan, G., 1996. Agonist activation of p42 and p44 mitogen-activated protein kinases following expression of the mouse delta opioid receptor in Rat-1 fibroblasts: effects of receptor expression levels and comparisons with G-protein activation. Biochem. J. 320, 227-235.
18. Cano, E., Mahadevan, L.C., 1995. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20, 117-122.
19. Chang, K.J., Cuatrecasas, P., 1979. Multiple opiate receptors: enkephalins and morphine bind to receptors of different specificity. J. Biol. Chem. 254, 2610-2618.
20. Chang, S.L., Squinto, S.P., Harlan, R.E., 1988. Morphine activation of c-fos expression in rat brain. Biochem. Biophys. Res. Commun. 157, 698-704.
21. Chen, Y., Mestek, A., Liu, J., Hurley, J.A., Yu, L., 1993. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44, 8-12.
22. Chesselet, M., Cheramy, A., Reisine, T., Lubetzki, C., Desban, M., Glowinski, J., 1983. Local and distal effects induced by unilateral striatal application of opiates in the absence or in the presence of naloxone on the release of dopamine in both caudate nuclei and substantive nigrae of the cat. Brain Res. 258, 229-242.
23. Childers, S.R., 1993. Opioid receptor-coupled second messenger systems. In: Herz, A. (Ed.), Opioids I., vol. 104. Springer-Verlag, Berlin, pp. 189-216.
24. Chu, P., Murray, S., Lissin, D., von Zastrow, M., 1997. Delta and kappa opioid receptors are differentially regulated by a dynamin-dependent endocytosis when activated by the same alkaloid agonist. J. Biol. Chem. 272, 27124-27130.
25. Cobb, M.H., Goldsmith, E.J., 1995. How MAP kinases are regulated. J. Biol. Chem. 270, 14843-14846.
26. Comb, M., Seeburg, P.H., Adelman, J., Eiden, L., Herbert, E., 1982. Primary structure of the human Met-and Leu-enkephalin precursor and its mRNA. Nature 295, 663-666.
27. Cooper, S.J., 1991. Interactions between endogenous opioids and dopamine: Implications for reward and aversion. In: Willner, P., Scheel-Kruger, J. (Eds.), The Mesolimbic Dopamine System: From Motivation to Action. John Wiley, England, pp. 331-366.
28. i-coupled receptor. Proc. Natl. Acad. Sci. U.S.A. 95, 352-357.
29. Cowie, A.L., Kosterlitz, H.W., Lydon, R.J., Waterfield, A.A., 1970. The effects of morphine-like substances and their antagonists on transmission at the neuro-effector junction of the myenteric plexus-longitudinal muscle preparation of the guinea-pig ileum. Br. J. Pharmacol. 38, 465P-466P.
30. Curran, E.J., in preparation.
31. Curran, E.J., Watson, S.J., 1995. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. J. Comp. Neurol. 361, 57-76.
32. Devine, D.P., Leone, P., Pocock, D., Wise, R.A., 1993. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J. Pharmacol. Exp. Ther. 266, 1236-1246.
33. Devine, D.P., Reinscheid, R., Monsma, F., Civelli, O., Akil, H., 1996a. The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res. 727, 225-229.
34. Devine, D.P., Taylor, L.P., Reinscheid, R.K., Monsma, F.J., Civelli, O., Akil, H., 1996b. Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem. Res. 21, 1387-1396.
35. Devine, D.P., Wise, R.A., 1994. Self-administration of morphine, DAMGO and DPDPE into the ventral tegmental area of rats. J. Neurosci. 14, 1978-1984.
36. Di Chiara, G., Imperato, A., 1988. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244, 1067-1080.
37. Emmerson, P.J., Clark, M.J., Mansour, A., Akil, H., Woods, J.H., Medzihradsky, F., 1996. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. J. Pharmacol. Exp. Ther. 278, 1121-1127.
38. Evans, C.J., Keith, D.E., Jr., Morrison, H., Magendzo, K., Edwards, R.H., 1992. Cloning of a delta opioid receptor by functional expression. Science 258, 1952-1955.
39. Fukuda, K., Kato, S., Morikawa, H., Shoda, T., Mori, K., 1996. Functional coupling of the delta-, mu-, and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J. Neurochem. 67, 1309-1316.
40. Gaudriault, Nouel D., Dal Farra, C., Beaudet, A., Vincent, J.-P., 1997. Receptor-induced internalization of selective peptidic μ and δ opioid ligands. J. Biol. Chem. 272, 2880-2888.
41. Goldstein, A., Aaronow, L., Kalman, S.M., 1968. Principles of Drug Action: The Basis of Pharmacology. Harper and Row, New York.
42. Goldstein, A., Lowney, L.I., Pal, B.K., 1971. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc. Natl. Acad. Sci. U.S.A. 68, 1742-1747.
43. Goldstein, A., Tachibana, S., Lowney, L.I., Hunkapiller, M., Hood, L., 1979. Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc. Natl. Acad. Sci. U.S.A. 76, 6666-6670.
44. Grevel, J., Sadee, W., 1983. An opiate binding site in the rat brain is highly selective for 4,5-epoxymorphinans. Science 221, 1198-1200.
45. Gulya, K., Pelton, J., Hruby, V., Yamamura, H., 1986. Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors. Life Sci. 30, 2221-2229.
46. Gutstein, H.B., Rubic, E.A., Mansour, A., Akil, H., Woodgett, J.R., 1997. Opioid effects on protein kinase signaling cascades. Anesthesiology, in press.
47. Gutstein, H.B., Thome, J.L., Fine, J.L., Watson, S.J., Akil, H., in press. The pattern of c-fos mRNA induction in rat brain by acute morphine. Can. J. Physiol. Pharmacol.
48. Handa, B., Lane, A., Lord, J., Morgan, B., Rance, M., Smith, C., 1981. Analogues of beta-LPH 61-64 possessing selective agonist activity at mu opiate receptors. Eur. J. Pharmacol. 70, 531-540.
49. Heimer, L., Switzer, R.D., Van Hoesen, G.W., 1982. Ventral striatum and ventral pallidum. Components of the motor system? Trends Neurosci. 5, 83-87.
50. Heimer, L., Zahm, D.S., Churchill, L., Kalivas, P.W., Wohltmann, C., 1991. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 41, 89-125.
51. Hill, C.S., Treisman, R., 1995. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80, 199-211.
52. Hokfelt, T., Ljungdahl, A., Terenius, L., Elde, R., Nilsson, C., 1977. The distribution of enkephalin-immunoreactive cell bodies in the rat central nervous system. Neurosci. Lett. 5, 25-31.
53. Hughes, J., Smith, T.W., Kosterlitz, H.W., Fothergill, L.A., Morgan, B.A., Morris, H.R., 1975. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258, 577-579.
54. Jenck, F., Moreau, J.L., Martin, J.R., et al., 1997. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. 94, 14854-14858.
55. 6]enkephalin and naltrindole 5′-isothiocyanate: evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 257, 1069-1075.
56. Kakidani, H., Furutani, Y., Takahashi, H., et al., 1982. Cloning and sequence analysis of cDNA for porcine beta-neo-endorphin/dynorphin precursor. Nature 298, 245-249.
57. Keith, D.E., Murray, S.R., Zaki, P.A., et al., 1996. Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem. 271, 19021-19024.
58. Kieffer, B., Befort, K., Gaveriaux-Ruff, C., Hirth, C., 1992. The delta opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. U.S.A. 89, 12048-12052.
59. Knapp, R.J., Landsman, R., Waite, S., et al., 1995. Properties of TAN-67, a nonpeptidic delta-opioid receptor agonist, at cloned human delta-and mu-opioid receptors. Eur. J. Pharmacol. 291, 129-134.
60. Kong, H., Raynor, K., Yano, H., Takeda, J., Bell, G.I., Reisine, T., 1994. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor. Proc. Natl. Acad. Sci. 91, 8042-8046.
61. Kong, H., Raynor, K., Yasuda, K., et al., 1993. A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding. J. Biol. Chem. 268, 23055-23058.
62. Kortenjann, M., Thomae, O., Shaw, P.E., 1994. Inhibition of v-raf-dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk 2. Mol. Cell Biol. 14, 4815-4824.
63. Krylova, O.Y., Shamakina, I.Y., Anokhin, K.V., 1993. Regulation of c-fos expression by acute and chronic morphine administration in rat brain. Neurosci. Res. Commun. 12, 133-140.
64. Li, L.Y., Chang, K.J., 1996. The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors. Mol. Pharmacol. 50, 599-602.
65. Liu, J., Nickolenko, J., Sharp, F.R., 1994. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. U.S.A. 91, 8537-8541.
66. Loh, H., Tseng, L.F., Wei, E., Li, C.H., 1976. β-Endorphin is a potent analgesic agent. Proc. Natl. Acad. Sci. U.S.A. 73, 2895.
67. Lord, J., Waterfield, A., Hughes, J., Kosterlitz, H., 1977. Endogenous opioid peptides: multiple agonists and receptors. Nature (London) 267, 495-499.
68. Mains, R.E., Eipper, B.A., Ling, N., 1977. Common precursor to corticotropins and endorphins. Proc. Natl. Acad. Sci. U.S.A. 74, 3014.
69. Mansour, A., Fox, C.A., Akil, H., Watson, S.J., 1995. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18, 22-29.
70. Mansour, A., Fox, C.A., Burke, A., et al., 1994. Mu, delta and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. Comp. Neurol. 350, 412-438.
71. 1 receptor mRNA distribution in the rat CNS: comparison to kappa receptor binding and prodynorphin mRNA. Cell Mol. Neurosci. 5, 124-144.
72. Mansour, A., Fox, C.A., Thompson, R.C., Akil, H., Watson, S.J., 1994b. Mu-opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding. Brain Res. 643, 245-265.
73. Mansour, A., Khatchaturian, H., Lewis, M.E., Akil, H., Watson, S.J., 1988. Anatomy of CNS opioid receptors. Trends Neurosci. 11, 308-314.
74. Mansour, A., Meng, F., Meador-Woodruff, J., Taylor, L., Civelli, O., Akil, H., 1992. Site-directed mutagenesis of the human D2 receptor. Eur. J. Pharmacol. 227, 205-214.
75. Mansour, A., Taylor, L.P., Fine, J.L., et al., 1997. Key residues defining the μ opioid receptor binding pocket: a site-directed mutagenesis study. J. Neurochem. 68, 344-353.
76. Martin, W., Eades, C., Thompson, J., Huppler, R., Gilbert, P., 1976. The effects of morphine and nalorphine-like drugs in nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197, 517-532.
77. Matthes, H.W.D., Maldonado, R., Simonin, F., et al., 1996. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid receptor. Nature 383, 819-823.
78. Meng, F., Hoversten, M., Thompson, R.C., Taylor, L., Watson, S.J., Akil, H., 1995. A chimeric study of the molecular basis of affinity and selectivity of the κ and the δ opioid receptors: potential role of extracellular domains. J. Biol. Chem. 270, 12730-12736.
79. Meng, F., Ueda, Y., Thompson, R.C., et al., 1996b. Mapping the receptor domains critical for the binding selectivity of δ opioid receptor ligands. Eur. J. Pharmacol. 311, 285-292.
80. Meng, F., Xie, G.X., Thompson, R.C., et al., 1993. Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc. Natl. Acad. Sci. U.S.A. 90, 9954-9958.
81. Mestek, A., Hurley, J.H., Bye, L.S., et al., 1995. The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase. Can. J. Neurosci. 15, 2396-2406.
82. 1 receptor. Nature 377, 532-535.
83. Minami, M., Toya, T., Katao, Y., et al., 1993. Cloning and expression of a cDNA for the rat κ-opioid receptor. FEBS Lett. 329, 291-295.
84. Mogil, J.S., Grisel, J.E., Zhangs, G., Belknap, J.K., Grandy, D.K., 1996. Functional antagonism of mu-, delta-and kappa-opioid antinociception by orphanin FQ. Neurosci. Lett. 214, 131-134.
85. Mollereau, C., Parmentier, M., Mailleux, P., et al., 1994. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341, 33-38.
86. Mosberg, H.I., Hurst, R., Hruby, V.J., et al., 1983. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc. Natl. Acad. Sci. U.S.A. 80, 5871-5874.
87. Mulder, A., Schoffelmeer, A., 1993. Multiple opioid receptors and presynaptic modulation of neurotransmitter release in the brain. In: Herz, A. (Ed.), Opioids I. Springer-Verlag, Berlin, pp. 125-144.
88. Mulder, A., Burger, D., Wardeh, G., Hogenboom, F., Frankhuyzen, A., 1991. Pharmacological profile of various kappa-agonists at kappa-, mu-and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Br. J. Pharmacol. 102, 518-522.
89. Nakanishi, S., Inoue, A., Kita, T., et al., 1979. Nucleotide sequence of clones cDNA for bovine corticotropin-beta-lipotropin precursor. Nature 278, 423.
90. Narita, M., Narita, M., Mizoguchi, H., Tseng, L.F., 1995. Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered mu-opioid receptor agonist in the mouse. Eur. J. Pharmacol. 280, R1-3.
91. Neal, C.R.J., Mansour, A., Civelli, O., Watson, S.J., 1998a. Localization of Orphanin FQ (Nociceptin) Peptide and Messenger RNA in the Brainstem and Spinal Cord of the Rat.
92. Neal, C.R.J., Mansour, A., Civelli, O., Watson, S.J., 1998b. Localization of Orphanin FQ (Nociceptin) Peptide and Messenger RNA in the Forebrain of the Rat.
93. Negri, L., Potenza, R.L., Corsi, R., Melchiorri, P., 1991. Evidence for two subtypes of δ opioid receptors in rat brain. Eur. J. Pharmacol. 196, 335-336.
94. Nestler, E.J., 1992. Molecular mechanisms of drug addiction. J. Neurosci. 12, 2439-2460.
95. Nestler, E.J., 1996. Under siege: the brain on opiates. Neuron 16, 897-900.
96. Nestler, E.J., Aghajanian, G.K., 1997. Molecular and cellular basis of addiction. Science 278, 58-63.
97. Nothacker, H.P., Reinscheid, R.K., Mansour, A., et al., 1996. Primary structure and tissue distribution of the orphanin FQ precursor. Proc. Natl. Acad. Sci. 93, 8622-8677.
98. Oka, T., 1980. Enkephalin receptor in the rabbit ileum. Life Sci. 38, 1889-1898.
99. Okuda-Ashitaka, E., Minami, T., Tachibana, S., Yoshihara, Y., Nishiuchi, Y.K.T., Ito, S., Nocistatin, a peptide that blocks nociceptor action in pain transmission. Nature 392 (6673) 286-289.
100. Ortiz, J., Harris, H.W., Guitart, X., Terwilliger, R.Z., Haycock, J.W., Nestler, E.J., 1995. Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: Regional distribution and regulation by chronic morphine. J. Neurosci. 15, 1285-1297.
101. Pan, Y.X., Xu, J., Pasternak, G.W., 1996. Cloning and expression of a cDNA encoding a mouse brain orphanin FQ/nociceptin precursor. Biochem. J. 315, 11-13.
102. Pasternak, G.W., 1986. Multiple morphine and enkephalin receptors: biochemical and pharmacological aspects. Ann. N.Y. Acad. Sci. 467, 130-139.
103. Pei, G., Kieffer, B.L., Lefkowitz, R.J., Freedman, N.J., 1995. Agonist-dependent phosphorylation of the mouse delta-opioid receptor: Involvement of G protein-coupled receptor kinases but not protein kinase C. Mol. Pharmacol. 48, 173-177.
104. Periyasamy, S., Hoss, W., 1990. Kappa opioid receptors stimulate phosphoinositide turnover in rat brain. Life Sci. 47, 219-225.
105. Pert, C., Snyder, S., 1973. Opiate receptor; demonstration in nervous tissue. Science 179, 1011-1014.
106. Piros, E.T., Hales, T.G., Evans, C.J., 1996. Functional analysis of cloned opioid receptors in transfected cell lines. Neurochem. Res. 21, 1271-1488.
107. Portoghese, P., Lipowski, A., Takemori, A., 1987. Binaltorphimine and norbinaltorphimine, potent and selective - κ-opioid receptor antagonists. Life Sci. 40, 1287-1292.
108. Portoghese, P., Sultana, M., Takemori, A., 1988. Natrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur. J. Pharmacol. 146, 185-186.
109. Prather, P.L., McGinn, T.M., Claude, P.A., Liu-Chen, L.Y., Loh, H.H., Law, P.Y., 1995. Properties of a kappa-opioid receptor expressed in CHO cells: interaction with multiple G-proteins is not specific for any individual G alpha subunit and is similar to that of other opioid receptors. Mol. Brain Res. 29, 336-346.
110. Reinscheid, R.K., Nothacker, H.-P., Bourson, A., et al., 1995. Orphanin FQ: a neuropeptide that activates an opioid-like G-protein-coupled receptor. Science 270, 792-794.
111. Rossomando, A.J., Payne, D.M., Weber, M.J., Sturgill, T.W., 1988. Evidence that pp42, a major tyrosine kinase target, is a mitogen-activated serine/threonine protein kinase. Proc. Natl. Acad. Sci. U.S.A. 86, 6940-6943.
112. Rothman, R.B., Long, J.B., Bykov, V., Jacobson, A.E., Rice, K.C., Holaday, J.W., 1988. β-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence. J. Pharmacol. Exp. Ther. 247, 405.
113. Schulz, R., Fease, E., Wuster, M., Herz, A., 1979. Selective receptors for β-endorphin on the rat vas deferens. Life Sci. 24, 843-850.
114. Schwyzer, R., 1986. Molecular mechanism of opioid receptor selection. Biochemistry 25, 6335-6342.
115. Seger, R., Krebs, E.G., 1995. The MAPK signaling cascade. FASEB J. 9, 726-735.
116. Segredo, V., Burford, N.T., Lameh, J., Sadee, S., 1997. A constitutively internalizing and recycling mutant of the μ-opioid receptor. J. Neurochem. 68, 2395-2404.
117. Self, D.W., Nestler, E.J., 1995. Molecular mechanisms of drug reinforcement and addiction. Ann. Rev. Neurosci. 18, 463-495.
118. Sharma, S.K., Klee, W.A., Nirenberg, M., 1977. Opiate-dependent modulation of adenylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 74, 3365-3369.
119. Shippenberg, T.S., Bals-Kubik, R., Huber, A., Herz, A., 1991. Neuroanatomical substrates mediating the aversive effects of D-1 dopa mine receptor antagonists. Psychopharmacology 103, 209-214.
120. Shippenberg, T.S., Herz, A., Spanagel, R., Bals-Kubik, R., Stein, C., 1992. Conditioning of opioid reinforcement: neuroanatomical and neurochemical substrates. Ann. N.Y. Acad. Sci. 654, 347-356.
121. 3H-etorphine to rat brain homogenate. Proc. Natl. Acad. Sci. U.S.A. 70, 1947-1949.
122. Simonin, F., Valverde, O., Smadja, C. et al., in press. Disruption of the κ-opioid receptor gene inmice enhances sensitivity to chemical visceral pain, impairs hypolocomotor, analgesic and aversive actions of the selective κ-agonist U-50, 488H and attenuates morphine withdrawal. EMBO J.
123. Sofuoglu, M., Portoghese, P.S., Takemori, A.E., 1991. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. J. Pharmacol. Exp. Ther. 257, 676-680.
124. Strader, C.D., Signal, I.S., Candelore, M.R., Rands, E., Hill, W.S., Dixon, R.A.F., 1988. Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. J. Biol. Chem. 263, 10267-10271.
125. Surratt, C.K., Johnson, P.S., Moriwaki, A., et al., 1994. Mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J. Biol. Chem. 269, 20548-20553.
126. Terenius, L., 1973. Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat brain cortex. Acta Pharmacol. Toxicol. (Copenh.) 32, 317-320.
127. Thompson, R.C., Mansour, A., Akil, H., Watson, S.J., 1993. Cloning and pharmacological characterization of a rat mu opioid receptor. Neuron 11, 903-913.
128. Trapaidze, N., Keith, D.E., Cvejic, S., Evans, C.J., Devi, L.A., 1996. Sequestration of the opioid receptor: role of the C terminus in agonist-mediated internalization. J. Biol. Chem. 271, 29279-29285.
129. Trujillo, K.A., Akil, H., 1991. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251, 85-87.
130. Tseng, L.F., Li, C.H., 1986. Beta-endorphin (1-27) inhibits the spinal beta-endorphin-induced release of met-enkephalin. Int. J. Pept. Protein Res. 27, 394-397.
131. i1-phospholipase C activation in Xenopus oocytes. J. Neurosci. 15, 7485-7499.
132. Ueda, H., Nozaki, M., Satoh, M., 1991. Multiple opioid receptors and GTP-binding proteins. Comp. Biochem. Physiol. 98C, 157-169.
133. Von Voightlander, P., Lahti, R., Ludens, J., 1983. U-50, 488H: a selective and structurally novel non-mu (kappa) opioid agonist. J. Pharmacol. Exp. Ther. 24, 111-115.
134. Wang, J.B., Imai, Y., Eppler, C.M., Gregor, P., Spivak, C.E., Uhl, G.R., 1993. μ opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. U.S.A. 90, 10230-10234.
135. Wang, J.-B., Johnson, P.S., Persico, A.M., Hawkins, A.L., Griffin, C.A., Uhl, G.R., 1994. Human μ opiate receptor cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett. 338, 217-222.
136. Watson, B., Meng, F., Thompson, R.C., Akil, H., 1995. Structural studies of the mu opioid receptor using chimeric constructs. Analgesia 1, 825-828.
137. Watson, S.J., Akil, H., Ghazarossian, V.E., Goldstein, A., 1981. Dynorphin immunocytochemical localization in brain and peripheral nervous system: preliminary studies. Proc. Natl. Acad. Sci. U.S.A. 78, 1260-1263.
138. Watson, S.J., Akil, H., Richard III, C.W., Barchas, J.D., 1978. Evidence for two separate opiate peptide neuronal systems. Nature 275, 226-228.
139. Winner, P., Ahlenius, S., Muscat, R., Scheel-Kruger, J., 1991. The mesolimbic dopamine system. In: Willner, P., Scheel-Kruger, J. (Eds.), The Mesolimbic Dopamine System: From Motivation to Action. John Wiley, England.
140. Xie, Y.B., Wang, H., Segaloff, D.L., 1990. Extracellular domain of lutropin/choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity. J. Biol. Chem. 265, 21411-21414.
141. Xue, J.C., Chen, C.-G., Zhu, J.M., et al., 1994. Differential binding domains of peptide and non-peptide ligands in the cloned rat κ opioid receptor. J. Biol. Chem. 269, 30195-30199.
142. Yasuda, K., Espinosa III, R., Takeda, J., Le Beau, M.M., Bell, G.I., 1994. Localization of the kappa opioid receptor gene to human chromosome band 8q11.2. Genomics 19, 596-597.
143. Yasuda, K., Raynor, K., Kong, H., et al., 1993. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc. Natl. Acad. Sci. U.S.A. 90, 6736-6740.
144. Zadina, J.E., Hackler, L., Ge, L.-J., Kastin, A.J., 1997. A potent and selective endogenous agonist for the μ-opiate receptor. Nature 386, 499-502.
145. Zagon, I., Goodman, S., McLaughlin, P., 1989. Characterization of zeta: a new opioid receptor involved in growth. Brain Res. 482, 297-305.
146. Zahm, D.S., Heimer, L., 1988. Ventral striatopallidal parts of the basal ganglia in the rat: I. Neurochemical compartmentation as reflected by the distributions of neurotensin and substance P immunoreactivity. J. Comp. Neurol. 272, 516-535.